This is the first supply of consistent, scalable, human muscle cells, providing transformative new models for drug discovery.
14.10.2021
Leading clinical immunotherapies developer Ramy Ibrahim joins bit.bio as Chief Medical Officer
Press release announcing appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer.
bit.bio joins maths institute to find the ‘operating system of life’
bit.bio joins forces with London institute of mathematical sciences to find the ‘operating system of life’.
Bit Bio secures $41.5 M of funding from top life sciences investors
bit.bio closes series A $41.5 million funding.
Bit Bio secures distribution agreement with Abcam
Bit Bio announces agreement with Abcam, to make Bit Bio’s iPSC derived functional human cells widely available.
Charles River announces Bit Bio partnership, increasing drug discovery technologies
bit.bio and Charles River announce strategic partnership.
Cambridge Start-Up of the Year
Elpis Wins 2018 Cambridge Independent Start-Up of the Year Award.